AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « real »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
reagent < real < realise  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000015 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000023 (2009) Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon]Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production
000029 (2011) Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000083 (2012) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000092 (2009) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
000331 (2012) Yoshikuni Mimata [Japon] ; Akihisa Kamataki ; Shinya Oikawa [Japon] ; Kenya Murakami [Japon] ; Miwa Uzuki ; Tadashi Shimamura [Japon] ; Takashi SawaiInterleukin‐6 upregulates expression of ADAMTS‐4 in fibroblast‐like synoviocytes from patients with rheumatoid arthritis
000366 (2013) J. E. Pope ; E. Rampakakis ; J. Sampalis ; O. Desjardins [Canada]FRI0187 The effectiveness of abatacept in a large RA real world database including durability and changes in haq over time: Post DMARDs and post TNF
000392 (2013) S. Bustabad ; J. J. Bethencourt ; M. Prieto Morales [Espagne] ; M. E. Peiro Callizo ; M. L. Gamir Gamir [Espagne]AB0697 Tocilizumab in systemic and polyarticular juvenile idiopathic arthritis: results of a retrospective evaluation in real-life clinical practice
000393 (2011) Masahiro Iwamoto [Japon] ; Sumiko Homma [Japon] ; Sachiko Onishi [Japon] ; Yasuyuki Kamata [Japon] ; Katsuya Nagatani [Japon] ; Zentaro Yamagata [Japon] ; Seiji Minota [Japon]Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season
000463 (2010) Luis Rodríguez-Rodríguez [Espagne] ; José Ram N Lamas [Espagne] ; Jezabel Varadé [Espagne] ; Pedro L Pez-Romero [Espagne] ; Pilar Tornero-Esteban [Espagne] ; Lydia Abasolo [Espagne] ; Emilio Gomez De La Concha [Espagne] ; Juan Angel Jover [Espagne] ; Elena Urcelay [Espagne] ; Benjamín Fernández-Gutiérrez [Espagne]Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity
000527 (2013) I. Ancuta ; C. Codreanu ; R. Ionescu ; M. Parvu [Roumanie] ; M. BojincaAB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data
000672 (2013) E. Rioux [Canada] ; I. Fortin [Canada] ; M.-J. Rioux [Canada]AB0314 The survival rates of biologics treated patients at the centre de rhumatologie de l’est du quebec : description of the real world, canadian patient cohort.
000694 (2013) S. Lanni ; F. Bovis ; E. Demirkaya ; R. Galasso ; A. Ravelli ; A. Martini ; N. Ruperto ; A. Pistorio [Italie]SAT0446 A Meta-Analysis to Assess the “Real” Placebo Effect in Juvenile Idiopathic Arthritis (JIA)
000764 (2013) H. Nü Lein ; R. Alten [Allemagne] ; M. Galeazzi [Italie] ; H. M. Lorenz [Allemagne] ; D. Boumpas [Grèce] ; M. T. Nurmohamed [Pays-Bas] ; W. G. Bensen [Canada] ; G. R. Burmester [Allemagne] ; H. H. Peter [Allemagne] ; F. Rainer [Autriche] ; K. Pavelka [République tchèque] ; M. Chartier ; C. Poncet [France] ; C. Rauch [Allemagne] ; M. Le Bars [France]AB0531 Real-world efficacy and safety of abatacept treatment for RA: 12-month interim analysis of the action study
000840 (2013) E. Fusaro [Italie] ; P. Tomietto ; P. Colombelli ; L. Abdi-Ali ; G. D Lessandro ; P. Prandini ; L. Di Matteo ; R. Giacomelli ; L. S. Martin Martin [Italie]FRI0230 Tocilizumab in the real clinical practice: a preliminary descriptive analysis from the italian observational trust study
000858 (2013) L. Gossec [France] ; S. Rouanet ; G. Steinberg ; B. Combe [France]THU0063 Does biologic treatment modify the relationship of the variables associated with fatigue in patients with rheumatoid arthritis? The peps study of tocilizumab in real life
000A68 (2012) R. Dinser [Allemagne] ; M. Frerix [Allemagne] ; U. Müller-Ladner [Allemagne]Klinische Präsentationen der Tuberkulose im Alltag
000B42 (2013) H. Nü Lein ; R. Alten [Allemagne] ; M. Galeazzi [Italie] ; H. M. Lorenz [Allemagne] ; D. Boumpas [Grèce] ; M. T. Nurmohamed [Pays-Bas] ; W. G. Bensen [Canada] ; G. R. Burmester [Allemagne] ; H.-H. Peter [Allemagne] ; F. Rainer [Autriche] ; K. Pavelka [République tchèque] ; M. Chartier ; C. Poncet [France] ; C. Rauch [Allemagne] ; M. Le Bars [France]FRI0235 Adherence to the recommended dosing regimen of abatacept: results from the international, real-world action study
000B53 (2013) P. Santos-Moreno ; L. Villarreal ; C. Sandoval [Colombie] ; A. P. Real ; P. Boon ; A. PalominoAB0784 Adherence rate to conventional dmards in patients with rheumatoid arthritis using biologics in a real-life setting
000B88 (2013) S. Johnston [États-Unis] ; D. Mcmorrow [États-Unis] ; A. M. Farr [États-Unis] ; P. Juneau [États-Unis] ; S. Ogale [États-Unis]SAT0566 Real World Study of Biologic Disease Modifying Antirheumatic Drug Persistence among Patients with Rheumatoid Arthritis who have Previously used at least One Other Biologic Agent: a U.S. Administrative Claims Database Analysis
000D39 (2009) David Jayne [Royaume-Uni]Treatment of ANCA‐associated systemic small‐vessel vasculitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "real" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "real" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    real
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021